Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
2.570
-0.110 (-4.10%)
At close: Apr 28, 2026, 4:00 PM EDT
2.590
+0.020 (0.78%)
After-hours: Apr 28, 2026, 7:44 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $212.21 million as of April 28, 2026. Its market cap has decreased by -60.18% in one year.
Market Cap
212.21M
Enterprise Value
26.03M
1-Year Change
-60.18%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has decreased from $467.51M to $212.21M, a decrease of -54.61%. That is a compound annual growth rate of -9.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvectis Pharma | 231.80M |
| Camp4 Therapeutics | 230.52M |
| Milestone Pharmaceuticals | 228.13M |
| Heron Therapeutics | 224.48M |
| Voyager Therapeutics | 224.09M |
| Keros Therapeutics | 217.09M |
| Context Therapeutics | 215.00M |
| ALX Oncology Holdings | 213.95M |